SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-218117
Filing Date
2012-05-08
Accepted
2012-05-08 15:09:48
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d339027d10q.htm 10-Q 513027
2 SECTION 302 CEO CERTIFICATION d339027dex311.htm EX-31.1 9906
3 SECTION 302 CFO CERTIFICATION d339027dex312.htm EX-31.2 9898
4 SECTION 906 CEO CERTIFICATION d339027dex321.htm EX-32.1 3479
5 SECTION 906 CFO CERTIFICATION d339027dex322.htm EX-32.2 3472
  Complete submission text file 0001193125-12-218117.txt   1858476

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcrx-20120331.xml EX-101.INS 222348
7 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20120331.xsd EX-101.SCH 8685
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20120331_cal.xml EX-101.CAL 30906
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20120331_lab.xml EX-101.LAB 95409
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20120331_pre.xml EX-101.PRE 57158
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 12821122
SIC: 2836 Biological Products, (No Diagnostic Substances)